REGENXBIO Inc. today announced data from its RGX-121 (clemidsogene lanparvovec) program for the treatment of mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome, will be shared at ...
The Blue Jays are entering a crucial final stretch of the offseason that won’t just determine how they perform next year, but for the rest of the decade and bey ...